Aehr Test Systems (NASDAQ:AEHR) shares, rose in value on Thursday, March 06, with the stock price down by -6.86% to the previous day’s close as strong demand from buyers drove the stock to $8.83.
Actively observing the price movement in the last trading, the stock closed the session at $9.48. The PE ratio was 11.83 over 12-month period. Referring to stock’s 52-week performance, its high was $21.44, and the low was $8.57. On the whole, AEHR has fluctuated by -20.38% over the past month.
With the market capitalization of Aehr Test Systems currently standing at about $262.36 million, investors are eagerly awaiting this quarter’s results, scheduled for in April.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that AEHR’s technical picture suggests that short-term indicators denote the stock is a 100% Sell on average. However, medium-term indicators have put the stock in the category of 100% Sell while long-term indicators on average have been pointing out that it is a 100% Sell.
The stock’s technical analysis shows that the price of AEHR currently trading nearly -14.99% and -29.28% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 34.60, while the 7-day volatility ratio is showing 8.41% which for the 30-day chart, stands at 6.47%. Furthermore, Aehr Test Systems (AEHR)’s beta value is 1.93, and its average true range (ATR) is 0.79.
A comparison of Aehr Test Systems (AEHR) with its peers suggests the former has fared considerably weaker in the market. AEHR showed an intraday change of -6.86% in last session, and over the past year, it shrunk by -47.22%%.
Data on historical trading for Aehr Test Systems (NASDAQ:AEHR) indicates that the trading volumes over the past 3 months, they’ve averaged 1.30 million. According to company’s latest data on outstanding shares, there are 29.71 million shares outstanding.
Nearly 6.32% of Aehr Test Systems’s shares belong to company insiders and institutional investors own 70.95% of the company’s shares. The stock has fallen by -46.90% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the AEHR stock heading into the next quarter.